(Press-News.org) Researchers at Baylor College of Medicine and the University of Michigan conducted a phase I pilot study to assess the feasibility of using potato starch as a dietary intervention to modify the gut microbiome in bone marrow transplant patients. The study, which appears in the journal Nature Medicine, is the first part of a two-phase ongoing clinical trial evaluating the effect of modifying the microbiome on the incidence of graft-versus-host disease (GVHD), a major complication that develops in up to half the patients who receive a bone marrow transplant and can lead to injury and death.
“The gut microbiome is a community of microbes we all carry inside the body, and its composition and products affect our health,” said senior and co-corresponding author Dr. Pavan Reddy, currently professor and director of the Dan L Duncan Comprehensive Cancer Center at Baylor and previously at the University of Michigan. “Early research from our lab and others showed that a normal gut microbiome and its products change after a bone marrow transplant and that this change contributes to GVHD aggravation. Can we alter the progression of GVHD by modifying the microbiome?”
Previous pre-clinical data from the Reddy lab demonstrated that butyrate, a compound produced by healthy intestinal bacteria when they digest resistant potato starch, a form of starch that people cannot digest, was significantly decreased in the gut of mice experiencing GVHD. Restoring butyrate levels by increasing intestinal butyrate-producing bacteria reduced experimental acute GVHD severity and mortality.
“Having more butyrate in the gut is helpful for healing the intestine, and therefore beneficial for alleviating GVHD,” Reddy said. “Previous studies have also shown that in healthy people, potato starch also promotes an increase in butyrate-producing bacteria and intestinal levels of butyrate.”
These findings led the researchers to investigate whether increasing intestinal butyrate-producing bacteria and intestinal butyrate levels in bone marrow transplant patients would reduce or prevent the progression of GVHD.
“We began by assessing in the current study whether it was safe and practical for 10 patients undergoing a bone marrow transplant at the University of Michigan to take a food supplement made from resistant potato starch for more than 100 days and whether this would change the products of the gut bacteria that live in the stomach and intestine in a way that could possibly prevent GVHD after transplant,” said first and co-corresponding author Dr. Mary Riwes, clinical assistant professor in medical oncology, internal medicine and hematology at the University of Michigan’s Rogel Cancer Center.
The goal was that 60% or more of the patients would take 70% or more of the potato starch doses. “Our findings surpassed our expectations,” Reddy said. “We found that more than 80% of the patients took 84% of the doses with no negative side effects, suggesting that it is safe and feasible for most patients to regularly take the food supplement. We also found that butyrate levels in the stools were significantly higher in the participants that took potato starch than in those that did not, as we had seen both in mice and healthy adults.”
“In the next part of the study, currently open at the University of Michigan and soon to open at a second site at Baylor College of Medicine, we will determine whether taking potato starch will indeed result in less GVHD after transplant,” Riwes said.
“It’s exciting that this is the first demonstration that a simple, safe dietary intervention has an effect on the gut microbiome and metabolites in these patients,” Reddy said. “Of the 10 patients in this study, only one developed GVHD, while typically about half of bone marrow transplant patients develop the condition. We have enrolled more patients in our ongoing phase 2 clinical trial to evaluate the value of potato starch in reducing the incidence of GVHD in transplant patients.”
“We could potentially be able to use a food substance in patients undergoing a bone marrow transplant, as a simple-to-administer, low-cost and relatively safe approach to prevent GVHD, which is a major limitation to the life-saving capability of a bone-marrow transplant,” Riwes said.
Jonathan L. Golob, John Magenau, Mengrou Shan, Gregory Dick, Thomas Braun, Thomas M. Schmidt, Attaphol Pawarode, Sarah Anand, Monalisa Ghosh, John Maciejewski, Darren King, Sung Choi, Gregory Yanik, Marcus Geer, Ethan Hillman, Costas A. Lyssiotis and Muneesh Tewari also contributed to this work.
This work was supported by the National Heart, Lung, and Blood Institute (grant no. P01 HL149633) and institutional startup funds.
###
END
Dietary supplement modifies gut microbiome – potential implications for bone marrow transplant patients
2023-10-20
ELSE PRESS RELEASES FROM THIS DATE:
Keeping a human in the loop: Managing the ethics of AI in medicine
2023-10-20
Artificial intelligence (AI)—of ChatGPT fame—is increasingly used in medicine to improve diagnosis and treatment of diseases, and to avoid unnecessary screening for patients. But AI medical devices could also harm patients and worsen health inequities if they are not designed, tested, and used with care, according to an international task force that included a University of Rochester Medical Center bioethicist.
Jonathan Herington, PhD, was a member of the AI Task Force of the Society for Nuclear Medicine and Medical Imaging, which laid out recommendations on how to ethically develop and use AI medical devices in two papers published ...
High pregnancy weight gain tied to higher risk of death in the following decades
2023-10-20
Pregnant people who gained more than the now-recommended amount of weight had a higher risk of death from heart disease or diabetes in the decades that followed, according to new analysis of 50 years of data published in The Lancet and led by researchers from the Perelman School of Medicine at the University of Pennsylvania. The group studied a large national data set that stretched from when a person gave birth through the next five decades, assessing mortality rates to show the potential long-term effects of weight gain in pregnancy. Higher risk of death was found for all weight groups studied — including those defined ...
First-of-its kind hormone replacement treatment shows promise in patient trials
2023-10-20
A first-of-its kind hormone replacement therapy that more closely replicates the natural circadian and ultradian rhythms of our hormones has shown to improve symptoms in patients with adrenal conditions. Results from the University of Bristol-led clinical trial are published today [20 October] in the Journal of Internal Medicine.
Low levels of a key hormone called ‘cortisol’ is typically a result of conditions such as Addison's and Congenital Adrenal Hyperplasia. The hormone regulates a range of vital processes, ...
For relationship maintenance, accurate perception of partner’s behavior is key
2023-10-19
URBANA, Ill. – Married couples and long-term romantic partners typically engage in a variety of behaviors that sustain and nourish the relationship. These actions promote higher levels of commitment, which benefits couples’ physical and psychological health. A new study from the University of Illinois Urbana-Champaign looks at how such relationship maintenance behaviors interact with satisfaction and commitment.
“Relationship maintenance is a well-established measure of couple behavior. In our study, we measured it with five main categories, ...
NASA's Webb discovers new feature in Jupiter’s atmosphere
2023-10-19
NASA’s James Webb Space Telescope has discovered a new, never-before-seen feature in Jupiter’s atmosphere. The high-speed jet stream, which spans more than 3,000 miles (4,800 kilometers) wide, sits over Jupiter’s equator above the main cloud decks. The discovery of this jet is giving insights into how the layers of Jupiter’s famously turbulent atmosphere interact with each other, and how Webb is uniquely capable of tracking those features.
“This is something that totally surprised us,” said Ricardo Hueso of the University of the Basque Country in Bilbao, Spain, lead author on the paper ...
MD Anderson research highlights: ESMO 2023 special edition
2023-10-19
ABSTRACTS: LBA71, 1088MO, 95MO, LBA48, 1082O, 1085O, LBA34, 243MO
MADRID ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
This special edition features upcoming oral presentations by MD Anderson researchers at the 2023 European Society for Medical Oncology (ESMO) Congress focused on clinical advances across a variety of cancer types. Highlights include a combination strategy for EGFR-mutant metastatic lung cancer, updated results for a Phase ...
To excel at engineering design, generative AI must learn to innovate, study finds
2023-10-19
ChatGPT and other deep generative models are proving to be uncanny mimics. These AI supermodels can churn out poems, finish symphonies, and create new videos and images by automatically learning from millions of examples of previous works. These enormously powerful and versatile tools excel at generating new content that resembles everything they’ve seen before.
But as MIT engineers say in a new study, similarity isn’t enough if you want to truly innovate in engineering tasks.
“Deep generative models (DGMs) are ...
Startup workers flee for bigger, more established companies during pandemic
2023-10-19
October 19, 2023
Startup workers flee for bigger, more established companies during pandemic
Findings reveal vulnerability of early-stage firms in downturns
Toronto - The world may have felt like it had stopped in the pandemic’s first weeks. But a “flight to safety” was underway at a popular digital job platform catering to the startup sector.
Digging into the data for nearly 180,000 users from AngelList Talent (now called Wellfound), the biggest online recruitment platform for private and entrepreneurial companies, researchers have found that U.S. job hunters turned away from smaller, early-stage companies in favour of positions at bigger, more established firms.
Just ...
Research repository arXiv receives $10M for upgrades
2023-10-19
ITHACA, N.Y. -- Cornell Tech has announced a total of more than $10 million in gifts and grants from the Simons Foundation and the National Science Foundation, respectively, to support arXiv, a free distribution service and open-access archive for scholarly articles.
The funding will allow the growing repository with more than 2 million articles to migrate to the cloud and modernize its code to ensure reliability, fault tolerance and accessibility for researchers.
“I am deeply grateful for this tremendous support from both the Simons Foundation ...
Electrons are quick-change artists in molten salts, chemists show
2023-10-19
In a finding that helps elucidate how molten salts in advanced nuclear reactors might behave, scientists have shown how electrons interacting with the ions of the molten salt can form three states with different properties. Understanding these states can help predict the impact of radiation on the performance of salt-fueled reactors.
The researchers, from the Department of Energy’s Oak Ridge National Laboratory and the University of Iowa, computationally simulated the introduction of an excess electron into molten zinc chloride salt to see what would happen.
They found three possible scenarios. In one, the electron becomes part of a molecular radical that ...